It is also possible for BOTH things to be true:
Post# of 148286
Cytodyn is trying to get data for 42 and 60 days, AND they are in discussions of the available with 28 day primary and secondary endpoints.
Your point on the timeline of 2 - 3 weeks is the best indication that regality discussions (EUA or approval) are not dependent on 60 day data.
Read More: https://investorshangout.com/post/newpost/605...z6nbJz4mVS